Apr 3, 2018 Cellectar Announces Issuance of U.S. Patent Covering CLR 131 Use in Multiple Myeloma Learn More
Mar 27, 2018 Cellectar Granted Seminal U.S. Patent for Phospholipid-Ether Analogs as Cancer-Targeting Drug Vehicles Learn More